Fundraising Fox

Recode VenturesFull Portfolio

11 tracked investments · listed companies and verified rows first

Caption Carecaption-care.com

Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease.

AI & Machine LearningDigital HealthMedical Devices

PartnerArmen A. Vidian· solo GP

Coincidence Labscoincidencelabs.comin

Coincidence Labs builds an AI orchestration layer that connects existing systems and digitizes paper records into a unified data layer, so AI agents can execute time-sensitive tasks like regulatory documentation with human review when needed.

Advanced ManufacturingAI & Machine LearningEnterprise Software

PartnerArmen A. Vidian· solo GP

LabGeniuslabgeni.usin𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Executive Officer, Director)in

PartnerArmen A. Vidian· solo GP

Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+9 more

Nanograbnanograb.comin𝕏

Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.

BiotechHealthtechSan Francisco, US

Debesh Mandal(Founder)inChristopher Lau(Founder)inShanil Panara(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsSterling RoadY Combinator

PatientGeniepatientgenie.ai

PartnerArmen A. Vidian· solo GP

Persona-Dxpersona-dx.com

PartnerArmen A. Vidian· solo GP

Probably Geneticprobablygenetic.comin𝕏

Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Lukas Lange(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAsymmetric Capital PartnersCalm/Storm VCManta Ray VenturesOxonian VenturesThreshold VenturesY Combinator+2 more

Propriopropriovision.comin𝕏

Proprio develops surgical technology using depth sensing and immersive image processing for the medical field.

AI & Machine LearningDeep TechHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)Joshua Smith(Co-founder)James Youngquist(Co-founder)

PartnerArmen A. Vidian· solo GP

Co-investorsBold Capital PartnersCota CapitalDCVC (Data Collective)Bird B. AGHTCPresence Capital+4 more

Sensible Biotechnologiessensible.bioin𝕏Feb 2023

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsCivilization Ventures Management, LlcKAYAY CombinatorZAKA VCBlueYard Capital

Verisianverisian.comin𝕏

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.

BiotechDigital HealthHealthtechSaaS

BoardSunil Gupta(Strategic Advisor)

PartnerArmen A. Vidian· solo GP

Co-investorsCambridge Angels groupSuperSeed

Waypoint Biowaypointbio.comin𝕏

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Tech

Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalMitsui Global InvestmentAmplify Partners CV+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.